TY - JOUR
T1 - Risk-Adjusted Cancer Screening and Prevention (RiskAP)
T2 - Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
AU - Schmutzler, Rita K.
AU - Schmitz-Luhn, Björn
AU - Borisch, Bettina
AU - Devilee, Peter
AU - Eccles, Diana
AU - Hall, Per
AU - Balmaña, Judith
AU - Boccia, Stefania
AU - Dabrock, Peter
AU - Emons, Günter
AU - Gaissmaier, Wolfgang
AU - Gronwald, Jacek
AU - Houwaart, Stefanie
AU - Huster, Stefan
AU - Kast, Karin
AU - Katalinic, Alexander
AU - Linn, Sabine C.
AU - Moorthie, Sowmiya
AU - Pharoah, Paul
AU - Rhiem, Kerstin
AU - Spranger, Tade
AU - Stoppa-Lyonnet, Dominique
AU - Van Delden, Johannes Jozef Marten
AU - Van Den Bulcke, Marc
AU - Woopen, Christiane
N1 - Publisher Copyright:
© 2022 S. Karger AG. All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Background: Risk-adjusted cancer screening and prevention is a promising and continuously emerging option for improving cancer prevention. It is driven by increasing knowledge of risk factors and the ability to determine them for individual risk prediction. However, there is a knowledge gap between evidence of increased risk and evidence of the effectiveness and efficiency of clinical preventive interventions based on increased risk. This gap is, in particular, aggravated by the extensive availability of genetic risk factor diagnostics, since the question of appropriate preventive measures immediately arises when an increased risk is identified. However, collecting proof of effective preventive measures, ideally by prospective randomized preventive studies, typically requires very long periods of time, while the knowledge about an increased risk immediately creates a high demand for action. Summary: Therefore, we propose a risk-adjusted prevention concept that is based on the best current evidence making needed and appropriate preventive measures available, and which is constantly evaluated through outcome evaluation, and continuously improved based on these results. We further discuss the structural and procedural requirements as well as legal and socioeconomical aspects relevant for the implementation of this concept.
AB - Background: Risk-adjusted cancer screening and prevention is a promising and continuously emerging option for improving cancer prevention. It is driven by increasing knowledge of risk factors and the ability to determine them for individual risk prediction. However, there is a knowledge gap between evidence of increased risk and evidence of the effectiveness and efficiency of clinical preventive interventions based on increased risk. This gap is, in particular, aggravated by the extensive availability of genetic risk factor diagnostics, since the question of appropriate preventive measures immediately arises when an increased risk is identified. However, collecting proof of effective preventive measures, ideally by prospective randomized preventive studies, typically requires very long periods of time, while the knowledge about an increased risk immediately creates a high demand for action. Summary: Therefore, we propose a risk-adjusted prevention concept that is based on the best current evidence making needed and appropriate preventive measures available, and which is constantly evaluated through outcome evaluation, and continuously improved based on these results. We further discuss the structural and procedural requirements as well as legal and socioeconomical aspects relevant for the implementation of this concept.
UR - http://www.scopus.com/inward/record.url?scp=85108600565&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/9639f6c7-0e79-3d83-ab9d-c76dfecb06d2/
U2 - 10.1159/000517182
DO - 10.1159/000517182
M3 - Scientific review articles
C2 - 35702492
AN - SCOPUS:85108600565
SN - 1661-3791
VL - 17
SP - 208
EP - 223
JO - Breast Care
JF - Breast Care
IS - 2
ER -